CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study.
Niu J, Qiu H, Xiang F, Zhu L, Yang J, Huang C, Zhou K, Tong Y, Cai Y, Dong B, Lu Y, Sun X, Wan L, Ding X, Wang H, Song X.
Niu J, et al. Among authors: qiu h.
Blood Cancer J. 2023 Mar 24;13(1):44. doi: 10.1038/s41408-023-00813-x.
Blood Cancer J. 2023.
PMID: 36964132
Free PMC article.
Clinical Trial.
No abstract available.